patients with unfavourable histology received depending on prognostic factors 4 courses of either vinblastine , actinomycin d and cyclophosphamide , or the combination of vinblastine , bleomycin and cisplatinum ( 4 courses ) completed by 4 additional courses of vp 16 , ifosfamide and cisplatinum .
C0010583
cyclophosphamide
C0020823
ifosfamide